Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,256 | 44,294 | 44,966 | 46,859 | 46,633 |
| Other current assets | 411 | 444 | 555 | 293 | 337 |
| TOTAL | $43,667 | $44,738 | $45,521 | $47,152 | $46,970 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 26 | 42 | 0 | 17 | 306 |
| TOTAL | $26 | $42 | $N/A | $17 | $306 |
| Total Assets | $43,693 | $44,780 | $45,521 | $47,169 | $47,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 331 | 331 | 331 | 331 | 331 |
| Accrued Expenses | 209 | 472 | 223 | 72 | 107 |
| Other current liabilities | N/A | N/A | N/A | 1,275 | N/A |
| TOTAL | $540 | $803 | $554 | $1,678 | $438 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $540 | $803 | $554 | $1,678 | $438 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,215 | 74,215 | 74,215 | 74,215 | 74,215 |
| Common Shares | 742 | 742 | 742 | 742 | 742 |
| Retained earnings | -72,230 | -71,406 | -70,416 | -69,892 | -69,820 |
| TOTAL | $43,153 | $43,977 | $44,967 | $45,491 | $46,838 |
| Total Liabilities And Equity | $43,693 | $44,780 | $45,521 | $47,169 | $47,276 |